Archer Daniels Midland 10-Kyear ended 2025-12-31

Executive Summary

ADM buys, transports and processes crops, earning trading and processing margins from food, feed, fuel and industrial customers and selling specialty nutrition ingredients. It is developing higher-value Nutrition products and lower-carbon agricultural solutions while simplifying operations and cutting costs. FY2025 showed the limits of that diversification: Nutrition improved, but weak oilseed-processing margins drove a second consecutive annual earnings decline. Net earnings fell 40%, while working-capital releases strengthened cash flow and supported debt repayment. The investor question is whether specialty growth and cost savings can offset commodity-margin pressure and uncertain trade and biofuel policies.

What's Happening in the Business

ADM’s largest business, Ag Services and Oilseeds, faced abundant crops, weaker North American soybean exports, disrupted U.S.–China trade and delayed U.S. biofuel policy. More processing did not mean better economics: oilseed volumes rose 1.7%, but lower soy and canola margins and higher manufacturing costs sharply reduced Crushing profit.

Management is pursuing enhanced nutrition, biotics, biosolutions and decarbonization alongside a cost program targeting more than $500M of cumulative savings over three to five years. Nutrition’s progress was uneven: Flavors benefited from North American demand, and Animal Nutrition improved through lower raw-material costs and cost optimization, while Health and Wellness margins weakened.

ADM also reduced investment intensity and changed its technology approach. Capital expenditures fell 20%, and regional digital projects replaced large global implementations, triggering a software impairment. Management expects FY2026 capital expenditures of ≈$1.4B, indicating that efficiency efforts are not a wholesale retreat from investment.

Key Financial Highlights

FY2025 comparisons are Y/Y.

• Crushing: Revenue fell 13% to $10.4B; operating profit dropped 81% to $159M, explaining most of Ag Services and Oilseeds’ deterioration. ADM received no significant 45Z clean-fuel tax-credit benefit, versus $316M under the predecessor biodiesel credit in FY2024.
• Carbohydrate Solutions: Starches and Sweeteners profit fell 21% to $1.06B as ethanol and starch margins weakened; Decatur insurance proceeds also fell to $9M from $84M. Vantage Corn Processors partly offset this, earning $152M versus $33M.
• Nutrition: Human Nutrition revenue grew 6.2% to $4.19B, but profit slipped 2.4% to $319M because ingredient and manufacturing costs offset commercial gains. Animal Nutrition profit rose 66% to $98M despite revenue falling 2.3% to $3.33B.
• Costs outside segments: Corporate costs increased 19% to $2.05B despite lower underlying unallocated spending. Results included $372M of investment revaluation losses, primarily alternative-protein investments, $283M of restructuring charges and a $179M software impairment.
• Cash quality and commitments: Against reported net earnings, cash flow benefited from $1.51B of inventory releases, $855M of receivables releases and $1.1B from brokerage-customer payables; these are not recurring profit growth. Purchase obligations due within a year were $12.5B, exceeding annual operating cash flow and requiring continued sales and financing.
• Capital returns: Dividends were broadly flat at $987M versus $985M. Repurchases stopped, versus $2.33B previously; year-end shares rose slightly rather than shrinking.

Risk Assessment

• Trade and biofuel policy: Disrupted soybean exports and delayed renewable-fuel rules directly affect ADM’s largest profit engine; expected future 45Z benefits depend on implementation and compliance.
• Financing access: All three major rating agencies maintained negative outlooks, while receivables securitization programs with $2.1B utilized terminate in 5/2026 unless extended; available liquidity of $10.4B provides a buffer.
• Investment recoverability: Wilmar’s $4.0B carrying value exceeded its $3.4B market value, while Animal Nutrition’s valuation cushion was only ≈15%, leaving exposure to further write-downs.
• Litigation: AOT/Maize plaintiffs allege damages of ≈$500M to more than $2.0B, and the intersegment-sales securities case survived dismissal motions; these remain claims, not established liabilities.
• Network disruption: Weather, waterway constraints and cyberattacks can interrupt ADM’s interconnected procurement, processing and shipping operations, increasing costs and working-capital needs.

What to Watch

• Crushing recovery: Profit is now $159M despite higher processing volumes. Better margins, soybean exports and realized 45Z benefits would support recovery; continued throughput growth without profit improvement would not.
• Nutrition’s growth quality: Human Nutrition sales grew while profit weakened. Stronger Flavors demand translating into profit, alongside sustained Animal Nutrition improvements, would validate the specialty strategy; further margin erosion would challenge it.
• Cost-program delivery: Management targets cumulative savings above $500M over three to five years. Lower underlying costs with stable commercial activity would demonstrate progress; repeated charges without improved profitability would weaken the case.
• Financing renewal: The utilized receivables programs require extension or replacement. Renewal and continued debt reduction would preserve flexibility; replacement at materially higher cost would absorb cash otherwise available for investment.